Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Lung clearance index short-term variability in cystic fibrosis. A pre-post pulmonary exacerbation study.
  • +5
  • M. De Marchis,
  • Enza Montemitro,
  • A. Boni,
  • A. Federici,
  • Daniele Di Giovanni,
  • L. Cristiani,
  • Renato Cutrera,
  • A.G. Fiocchi
M. De Marchis
Ospedale Pediatrico Bambino Gesu

Corresponding Author:[email protected]

Author Profile
Enza Montemitro
Ospedale Pediatrico Bambino Gesu
Author Profile
A. Boni
Ospedale Pediatrico Bambino Gesu
Author Profile
A. Federici
Ospedale Pediatrico Bambino Gesu
Author Profile
Daniele Di Giovanni
Universita degli Studi di Roma Tor Vergata Dipartimento di Ingegneria Industriale
Author Profile
L. Cristiani
Ospedale Pediatrico Bambino Gesu
Author Profile
Renato Cutrera
Ospedale Pediatrico Bambino Gesu
Author Profile
A.G. Fiocchi
Ospedale Pediatrico Bambino Gesu
Author Profile

Abstract

Background: Multiple Breath washout (MBW) represents an important tool to detect early a possible pulmonary exacerbation especially in Cystic Fibrosis (CF) disease. Lung clearance index (LCI) is the most commonly reported multiple breath washout (MBW) index and in the last years was used as management measure for evaluation. Our aim was to analyze clinical utility of LCI index variability in pulmonary exacerbation in CF. Methods: A single-center study was conducted at CF Unit of Bambino Gesù Children’s Hospital among hospitalized > 3 years patients for pulmonary exacerbations and treated with antibiotic intravenous treatment for 14 days. MBW and spirometry were evaluated within 72 hours of admission to hospital and at the end of hospitalization. Descriptive analysis was conducted and correlations between quantitative variables were investigated. Results: Fifty-seven patients (M22/F35) with an average age 18.56 (± 8.54) years were enrolled. LCI 2.5 was significantly reduced at the end of antibiotic treatment in both pediatric and adult populations with an average improvement of -6% in 37/57 patients. 26/57 are stable in LCI values. A significant elevation of +7.30% was found for FEV1%. 4/57 (7.02 %) had a significant deterioration in LCI values at the end of IV antibiotic treatment. A positive good correlation among LCI 2.5 and Scond (rho= +0.615, p=0.000) and LCI 2.5 and Sacin (rho=+0.649, p=0.000) and a negative strong correlation between FEV1% and LCI 2.5 were found in post treatment period. A better increase of LCI 2.5 in < 18 years (-10.27% vs -4.57%) than adult was noticed. Conclusions: LCI may have a role in the routine clinical care of CF patients as a good tool to assess response to intravenous antibiotic therapy.